Dambkowski Carl sold APGE
April 1, 2026 · Form 4 insider transaction
Dambkowski Carl sold 100 shares of Apogee Therapeutics, Inc. at $85.89 per share, a transaction worth $8.6K. The trade was recorded as open-market sale under a pre-scheduled Rule 10b5-1 plan and disclosed on an SEC Form 4, filed 2 days after the transaction.
Direction
Disposed (sell-side)
Shares
100
Price
$85.89
Total value
$8.6K
InsiderDambkowski Carl
Role—
SecurityCommon Stock
Transaction codeS: Open-market sale
Transaction dateApril 1, 2026
Filing dateApril 3, 2026
Shares owned after208,398
OwnershipDirect
10b5-1 planYes
AmendedNo
Footnotes
This transaction was executed pursuant to a Rule 10b5-1 trading plan adopted on September 22, 2025.